ResMed ROE 2006-2018 | RMD

Current and historical return on equity (ROE) values for ResMed (RMD) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. ResMed ROE for the three months ending December 31, 2018 was 26.53%.
ResMed ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2018-12-31 $0.45B $1.96B 22.60%
2018-09-30 $0.34B $1.90B 16.70%
2018-06-30 $0.32B $2.06B 15.42%
2018-03-31 $0.31B $2.07B 15.22%
2017-12-31 $0.29B $2.02B 14.51%
2017-09-30 $0.35B $2.05B 18.64%
2017-06-30 $0.34B $1.96B 18.80%
2017-03-31 $0.32B $1.86B 18.43%
2016-12-31 $0.33B $1.71B 19.09%
2016-09-30 $0.35B $1.77B 20.77%
2016-06-30 $0.35B $1.70B 22.23%
2016-03-31 $0.36B $1.67B 22.87%
2015-12-31 $0.36B $1.52B 23.38%
2015-09-30 $0.35B $1.46B 22.81%
2015-06-30 $0.35B $1.59B 22.12%
2015-03-31 $0.35B $1.54B 21.61%
2014-12-31 $0.35B $1.59B 21.05%
2014-09-30 $0.35B $1.65B 20.65%
2014-06-30 $0.35B $1.76B 20.41%
2014-03-31 $0.33B $1.69B 19.96%
2013-12-31 $0.33B $1.64B 19.43%
2013-09-30 $0.32B $1.69B 18.58%
2013-06-30 $0.31B $1.61B 17.98%
2013-03-31 $0.31B $1.77B 18.22%
2012-12-31 $0.29B $1.75B 17.46%
2012-09-30 $0.28B $1.70B 17.04%
2012-06-30 $0.26B $1.61B 16.18%
2012-03-31 $0.24B $1.61B 14.70%
2011-12-31 $0.23B $1.56B 13.84%
2011-09-30 $0.22B $1.55B 13.43%
2011-06-30 $0.23B $1.73B 13.95%
2011-03-31 $0.22B $1.66B 14.64%
2010-12-31 $0.22B $1.61B 15.21%
2010-09-30 $0.21B $1.48B 15.31%
2010-06-30 $0.19B $1.29B 14.96%
2010-03-31 $0.18B $1.33B 14.83%
2009-12-31 $0.17B $1.26B 15.13%
2009-09-30 $0.16B $1.20B 15.04%
2009-06-30 $0.15B $1.12B 14.51%
2009-03-31 $0.13B $0.97B 13.13%
2008-12-31 $0.12B $0.96B 11.93%
2008-09-30 $0.12B $0.97B 11.11%
2008-06-30 $0.11B $1.08B 10.70%
2008-03-31 $0.11B $1.07B 10.91%
2007-12-31 $0.06B $1.02B 6.74%
2007-09-30 $0.07B $0.98B 7.26%
2007-06-30 $0.07B $0.93B 7.82%
2007-03-31 $0.06B $0.87B 7.67%
2006-12-31 $0.10B $0.85B 13.58%
2006-09-30 $0.10B $0.77B 14.18%
2006-06-30 $0.09B $0.74B 14.25%
2006-03-31 $0.08B $0.67B 14.69%
2005-12-31 $0.07B $0.53B 14.63%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $14.469B $2.340B
ResMed Inc. is a world-leading connected health company with cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its award-winning devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $140.623B 27.80
Medtronic (MDT) Ireland $123.520B 18.06
Stryker (SYK) United States $73.875B 27.09
Boston Scientific (BSX) United States $52.874B 25.78
Baxter (BAX) United States $40.209B 25.72
Zimmer Biomet Holdings (ZBH) United States $26.486B 16.96
Smith & Nephew SNATS (SNN) United Kingdom $17.634B 0.00
Canopy Growth (CGC) Canada $15.407B 0.00
Aurora Cannabis (ACB) Canada $9.687B 68.36
Bio-Rad Laboratories (BIO) United States $9.455B 53.94
Hill-Rom Holdings (HRC) United States $7.140B 22.08
Perrigo (PRGO) Ireland $6.601B 10.70
Insulet (PODD) United States $6.039B 2037.40
GW Pharmaceuticals (GWPH) United Kingdom $5.309B 0.00
ICU Medical (ICUI) United States $4.841B 30.14
Haemonetics (HAE) United States $4.496B 39.88
Hutchison China MediTech (HCM) China $3.961B 0.00
Agios Pharmaceuticals (AGIO) United States $3.830B 0.00
Neogen (NEOG) United States $3.332B 51.18
NuVasive (NUVA) United States $2.927B 25.53
Quidel (QDEL) United States $2.672B 24.11
Aphria (APHA) $2.518B 111.78
National Vision Holdings (EYE) United States $2.327B 45.77
HEXO (HEXO) $1.429B 0.00
Cardiovascular Systems (CSII) United States $1.402B 1006.25
Phibro Animal Health (PAHC) United States $1.308B 18.80
VAREX IMAGING (VREX) United States $1.299B 25.44
AtriCure (ATRC) United States $1.104B 0.00
Lantheus Holdings (LNTH) United States $0.968B 26.15
MacroGenics (MGNX) United States $0.967B 0.00
Cerus (CERS) United States $0.885B 0.00
PetIQ (PETQ) United States $0.872B 24.96
Omeros (OMER) United States $0.868B 0.00
NanoString Technologies (NSTG) United States $0.753B 0.00
Meridian Bioscience (VIVO) United States $0.727B 21.67
OraSure Technologies (OSUR) United States $0.713B 31.24
Eagle Pharmaceuticals (EGRX) United States $0.705B 23.99
Evolus (EOLS) United States $0.701B 0.00
TG Therapeutics (TGTX) United States $0.650B 0.00
Surmodics (SRDX) United States $0.618B 89.94
LeMaitre Vascular (LMAT) United States $0.614B 29.21
Quanterix (QTRX) United States $0.551B 0.00
BioLife Solutions (BLFS) United States $0.397B 163.54
Vapotherm (VAPO) United States $0.371B 0.00
Rockwell Medical (RMTI) United States $0.363B 0.00
Insys Therapeutics (INSY) United States $0.358B 0.00
Utah Medical Products (UTMD) United States $0.312B 20.30
Owens & Minor (OMI) United States $0.284B 3.94
Bovie Medical (APYX) United States $0.264B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.257B 0.00
Cytosorbents (CTSO) United States $0.255B 0.00
Zynex (ZYXI) United States $0.143B 15.35
Fonar (FONR) United States $0.143B 7.64
Surface Oncology (SURF) United States $0.117B 0.00
Chimerix (CMRX) United States $0.102B 0.00
Female Health (VERU) United States $0.100B 0.00
Chembio Diagnostics (CEMI) United States $0.097B 0.00
InfuSystems Holdings (INFU) United States $0.090B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.088B 0.00
United-Guardian (UG) United States $0.087B 20.01
CAS Medical Systems (CASM) United States $0.071B 0.00
Trinity Biotech (TRIB) Ireland $0.071B 21.00
Neurotrope (NTRP) United States $0.061B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Valeritas Holdings (VLRX) United States $0.036B 0.00
Senestech (SNES) United States $0.028B 0.00
Myomo (MYO) United States $0.022B 0.00
Capricor Therapeutics (CAPR) United States $0.018B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.015B 0.00
Akers Biosciences Inc (AKER) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
NeuroMetrix (NURO) United States $0.009B 15.57